Could a pill replace chemo for some breast cancer patients?
NCT ID NCT05296746
First seen Jun 26, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This phase 2 trial is testing whether a combination of ribociclib (Kisqali) and letrozole can safely replace chemotherapy for people with high-risk ER+/HER2- breast cancer. About 1100 participants will first receive the drug combo before surgery. If their tumor shows a low risk of recurrence after six months, they continue the same treatment after surgery instead of chemo. The goal is to see if this approach can keep cancer from spreading while avoiding chemo's harsh side effects.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- Active substance
- Ribociclib (Kisqali) plus letrozole
- What this could lead to
- If successful, this could allow some high-risk breast cancer patients to avoid chemotherapy and its side effects by using a targeted drug combination instead.
- What could go wrong
- This is a phase 2 trial with 1100 participants, so results are still preliminary. It only applies to patients whose tumors show a low genomic risk after initial treatment, and long-term benefits are not yet proven.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER STAGE II are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Centre Eugène Marquis
Rennes, France
-
Centre François Baclesse
Caen, France
-
Centre Georges François Leclerc
Dijon, France
-
Centre Hospitalier Bretagne Atlantique
Vannes, France
-
Centre Hospitalier Privé Saint-Grégoire
Saint-Grégoire, France
-
Centre Hospitalier Universitaire de Besancon
Besançon, France
-
Centre Hospitalier Universitaire de Grenoble Alpes
Grenoble, France
-
Centre Hospitalier Universitaire de Limoges
Limoges, France
-
Centre Hospitalier Universitaire de Poitiers
Poitiers, France
-
Centre Hospitalier de Cholet
Cholet, France
-
Centre Hospitalier de la Côte Basque
Bayonne, France
-
Centre Hospitalier les Cornouaille
Quimper, France
-
Centre Jean Perrin
Clermont-Ferrand, France
-
Centre Léon Berard
Lyon, France
-
Centre Oscar lambret
Lille, France
-
Clinique Mutualiste de l'Estuaire - Groupe HGO
Saint-Nazaire, France
-
Clinique Pasteur
Toulouse, France
-
Clinique Sainte Anne - Strasbourg Oncologie Libérale
Strasbourg, France
-
Complejo Asistencial Universitario de León
León, Spain
-
Complejo Asistencial Universitario de Salamanca
Salamanca, Spain
-
Fundación Jiménez Díaz
Madrid, Spain
-
Gustave Roussy
Villejuif, France
-
HM Sanchinarro
Madrid, Spain
-
Hopitaux du Léman
Thonon-les-Bains, France
-
Hospital 12 de Octubre
Madrid, Spain
-
Hospital Clinic de Barcelona
Barcelona, Spain
-
Hospital Clínico de Valencia
Valencia, Spain
-
Hospital Ramón y Cajal
Madrid, Spain
-
Hospital Son Espases
Palma de Mallorca, Balearic Islands, Spain
-
Hospital Universiatrio Clínico San Cecilio
Granada, Spain
-
Hospital Universitario Virgen del Rocío
Seville, Spain
-
Hospital Vall d'Hebron
Barcelona, Spain
-
Hospital da Luz
Lisbon, Portugal
-
Hospital de São Francisco Xavier
Lisbon, Portugal
-
Hôpital Franco Britanique Fondation Cognacq Jay
Levallois-Perret, France
-
Hôpital Simone veil de Blois
Blois, France
-
Hôpital privé Jean Mermoz
Lyon, France
-
Hôpital privé de Confluent
Nantes, France
-
ICO Badalona
Badalona, Barcelona, Spain
-
ICO Hospitalet
L'Hospitalet de Llobregat, Barcelona, Spain
-
IPO Porto
Porto, Portugal
-
Institut Claudius Regaud, IUCT-Oncopole
Toulouse, France
-
Institut Curie
Paris, France
-
Institut Curie
Saint-Cloud, France
-
Institut Jean Godinot
Reims, France
-
Institut Paoli Calmettes
Marseille, France
-
Institut de Cancérologie de Lorraine
Vandœuvre-lès-Nancy, France
-
Institut de cancérologie Strasbourg Europe - ICANS
Strasbourg, France
-
Instituto Valenciano de Oncología
Valencia, Spain
-
Nouvelle Clinique des Dentellières
Valenciennes, France
-
Sainte Catherine - Institut du Cancer Avignon Provence
Avignon, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- New drug cocktail aims to wipe out breast cancer before surgery
- Can a chemo pill mop up hidden breast cancer cells?
- Cooler caps may keep hair on during chemo
- Could a pill replace chemo for older breast cancer patients?
- Tape or laser: which eases Post-Mastectomy arm swelling better?
- Small study aims to predict which breast cancer patients benefit from immunotherapy